Dave Morrow

Dave Morrow has over 28 years of work experience in various roles in the biotechnology and healthcare industries. Dave is currently employed by Talis Biomedical Corporation as the Vice President of Platform Development, a position they have held since July 2021. Prior to that, from August 2020 to July 2021, they served as the Vice President of Manufacturing Development at the same company.

Before joining Talis Biomedical Corporation, Dave worked at Endotronix, Inc. as the Vice President of Research and Development from September 2017 to August 2020. During their tenure, they led the development of a Class III implantable heart failure sensor and various medical systems, successfully completing a clinical trial and obtaining FDA approval for a larger trial.

From 2013 to 2017, Dave held the position of Vice President of Platform Development at Nanosphere, which was later acquired by Luminex and became Diasorin. In this role, they were responsible for executing the company's clinical diagnostics platform strategy and leading product development efforts.

Dave's career at Nanosphere began in 2001, where they held multiple roles, including Associate Director of Software Engineering and Senior Software/Systems Engineer. During this time, they played a key role in designing and developing Nanosphere's IVD technology.

Prior to their tenure at Nanosphere, Dave worked as a Senior Software Engineer at Baxter International Inc. from 1993 to 2001.

Dave Morrow attended DePaul University and obtained a Bachelor of Science degree in Physics. Dave also pursued graduate coursework at the same university in Applied Mathematics. However, no specific start or end years have been provided for these educational experiences.